Preparation and evaluation of iopamidol Parenteral formulation

  • Kamlesh Machewar Taywade College of Pharmacy, Mahadula, Koradi Colony Tah.: Kamptee, Dist.: Nagpur - 441111 (Maharashtra)
  • Vijendra Kharabe Bhopal Institute of Technology & Science, Bhopal, Madhya Pradesh 462045
Keywords: iopamidol, Parenteral formulation, contrast media


Parenteral administration offers many advantages over therapy, given by non parenteral routes. Most notably, therapeutics can reliably predict with considerably accuracy, the Pharmacokinetic and Pharmacology of the agents. Despite of these advantages, parenteral administration is not without certain, measurable risks and limitation that the professional must intelligently weigh in terms of risks benefits, and costs. Iopamidol is radio opaque Nonionic contrast media used parenterally for diagnostic purpose. Solubility of iopamidol is very limited in water. Various Marketed formulations suffer the problem of crystallization of Iopamidol; such crystallization is very crucial as it will vary the dose and also effective drug in the solubilized form is minimized.


Download data is not yet available.


. Rutten A, Prokop M. Contrast agents in X-ray computed tomography and its applications in oncology. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2007 May 1;7(3):307-16.

. Mckinstry DN, Rommel AJ, Sugerman AA. Pharmacokinetics, Metabolism, and Excretion of Iopamidol in Healthy Subjects. Investigative Radiology. 1984 Sep 1;19(5):S171-174.

. Motola,S., Biopharmaceutics Of Injectables Medication In Pharmaceutical Dosage Form Parenteral Medication, Marcel Dekker, Inc. Vol. 1.(2ND ED)., PP. 59 (1995).

. Kawada TK. Iohexol and iopamidol: second-generation nonionic radiographic contrast media. Drug Intell Clin Pharm Jul/Aug; 19: 525-9. 1985

. Almen T. Contrast media: the relation of chemical structure, animal toxicity and adverse clinical effects. Am J Cardiol; 66: 2F-8F. 1990

. Reagents: Volumetric Solutions - Available from URL:

. Atemnkeng MA, Plaizier-Vercammen J, Schuermans A. Comparison of free and bound iodine and iodide species as a function of the dilution of three commercial povidone-iodine formulations and their microbicidal activity. Int J Pharm. 2006 Jul 24; 317(2):161-6.

. Brinker JA. Selection of a contrast agent in the cardiac catheterization laboratory. Am J Cardiol; 66: 26F-33F. 1990

. Swanson DP, Chilton HM, Thrall JH, editors. Pharmaceuticals in medical imaging. New York: MacMillan Publishing Company,: 1-35, 125-54, 253-77. 1990

. Martin FIR, Tress BW, Colman PG, et al. Iodine-induced hyperthyroidism due to nonionic contrast radiography in the elderly. Am J Med; 95: 78-82. 1993

. Isovue (Squibb). In: Krogh CME, editor. CPS Compendium of pharmaceuticals and specialties. 29th ed. Ottawa: Canadian Pharmaceutical Association, 1994: 638.

. Motola, S., Agharkr, S. N., Preformulation Research Of Parenteral Medication in Pharmaceutical Dosage Form Parenteral Medication, Marcel Dekker, Inc. Vol. 1.(2ND ED)., PP. 59 (1995).

. Simonelli, A.P. And Dresback, D.S., In Perspectives In Clinical Pharmacy, Drug Inteligence Publication, Hamilton, Lllinois, PP. 390-420, (1972).

. Kostendauder, H.B., Rapp, R P., Mc. Govren J.P., Foster, T.S. Perrier D.G., Blacker, H.M., Hulon W.C., and Kinkel,A.W., Clinical Pharmacology Ther., 18 PP. 449 (1975)

How to Cite
Machewar K, Kharabe V. Preparation and evaluation of iopamidol Parenteral formulation. IJAP [Internet]. 30Jun.2014 [cited 21Jan.2019];3(3):32-5. Available from:
Research Articles